VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹61 Cr | ₹88 Cr | ₹59 Cr | ₹37 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of VIMTA LABS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹61 Cr |
Mar2023 | ₹88 Cr |
Mar2022 | ₹59 Cr |
Mar2021 | ₹37 Cr |
Mar2020 | ₹24 Cr |
How is Cash Flow from Operating Activities of VIMTA LABS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹61 Cr | -30.75 | |
Mar2023 | ₹88 Cr | 48.87 | |
Mar2022 | ₹59 Cr | 58.86 | |
Mar2021 | ₹37 Cr | 52.71 | |
Mar2020 | ₹24 Cr | - |
Compare Cash Flow from Operating Activities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,320.2 Cr | 19.2% | 6.5% | 89.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 19.2% |
6.5% |
89.7% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses